| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | 26.75% | JP Morgan | $218 → $236 | Maintains | Overweight |
| 10/17/2023 | 7.42% | Citigroup | $230 → $200 | Maintains | Buy |
| 10/17/2023 | 12.79% | Wells Fargo | $215 → $210 | Maintains | Overweight |
| 10/16/2023 | -9.23% | Morgan Stanley | $212 → $169 | Maintains | Equal-Weight |
| 09/27/2023 | 17.08% | JP Morgan | $265 → $218 | Maintains | Overweight |
| 09/14/2023 | 13.86% | Morgan Stanley | $213 → $212 | Maintains | Equal-Weight |
| 08/22/2023 | 10.1% | Raymond James | $211 → $205 | Maintains | Outperform |
| 08/07/2023 | 22.46% | Barclays | $233 → $228 | Maintains | Overweight |
| 08/01/2023 | 23.53% | RBC Capital | $233 → $230 | Maintains | Outperform |
| 07/28/2023 | 13.33% | Raymond James | $238 → $211 | Maintains | Outperform |
| 07/18/2023 | 15.47% | Wells Fargo | $245 → $215 | Maintains | Overweight |
| 07/13/2023 | 23.53% | BMO Capital | → $230 | Initiates Coverage On | → Outperform |
| 05/17/2023 | 14.4% | Morgan Stanley | $215 → $213 | Maintains | Equal-Weight |
| 05/01/2023 | 25.14% | Barclays | $229 → $233 | Maintains | Overweight |
| 04/27/2023 | 27.83% | Raymond James | $227 → $238 | Maintains | Outperform |
| 04/18/2023 | 15.47% | Morgan Stanley | $224 → $215 | Maintains | Equal-Weight |
| 03/30/2023 | 25.68% | MoffettNathanson | $244 → $234 | Upgrades | Market Perform → Outperform |
| 03/23/2023 | 22.99% | Barclays | $246 → $229 | Maintains | Overweight |
| 03/07/2023 | 31.05% | Jefferies | $239 → $244 | Maintains | Buy |
| 03/06/2023 | 23.53% | RBC Capital | $240 → $230 | Maintains | Outperform |
| 03/02/2023 | 18.16% | Argus Research | $250 → $220 | Maintains | Buy |
| 02/24/2023 | 45.55% | TD Cowen | $279 → $271 | Maintains | Outperform |
| 02/24/2023 | 21.92% | Raymond James | $233 → $227 | Maintains | Outperform |
| 02/24/2023 | 31.05% | Credit Suisse | $251 → $244 | Maintains | Outperform |
| 02/08/2023 | 32.12% | Barclays | $247 → $246 | Maintains | Overweight |
| 01/23/2023 | 20.31% | Morgan Stanley | $219 → $224 | Maintains | Equal-Weight |
| 01/23/2023 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 01/13/2023 | 47.7% | Truist Securities | $325 → $275 | Maintains | Buy |
| 01/12/2023 | 36.42% | Deutsche Bank | $240 → $254 | Upgrades | Hold → Buy |
| 01/10/2023 | 31.59% | Goldman Sachs | $215 → $245 | Upgrades | Neutral → Buy |
| 11/23/2022 | 25.14% | Raymond James | $219 → $233 | Maintains | Market Outperform |
| 11/14/2022 | 32.66% | Barclays | $232 → $247 | Maintains | Overweight |
| 11/08/2022 | 34.81% | Jefferies | $258 → $251 | Maintains | Buy |
| 11/08/2022 | 28.9% | B of A Securities | $315 → $240 | Maintains | Buy |
| 11/01/2022 | 28.9% | RBC Capital | $265 → $240 | Maintains | Outperform |
| 10/28/2022 | 49.31% | UBS | $305 → $278 | Maintains | Buy |
| 10/28/2022 | 20.84% | Wells Fargo | $235 → $225 | Maintains | Overweight |
| 10/28/2022 | 17.62% | Raymond James | $274 → $219 | Maintains | Outperform |
| 10/28/2022 | 35.35% | Keybanc | $264 → $252 | Maintains | Overweight |
| 10/20/2022 | 24.6% | Barclays | $290 → $232 | Maintains | Overweight |
| 10/18/2022 | 12.25% | Morgan Stanley | $257 → $209 | Maintains | Equal-Weight |
| 10/18/2022 | 26.22% | Wells Fargo | $300 → $235 | Maintains | Overweight |
| 10/12/2022 | 15.47% | Goldman Sachs | $250 → $215 | Maintains | Neutral |
| 10/07/2022 | 63.81% | UBS | $315 → $305 | Maintains | Buy |
| 10/07/2022 | 24.6% | Deutsche Bank | $285 → $232 | Maintains | Hold |
| 10/03/2022 | 41.79% | Keybanc | $300 → $264 | Maintains | Overweight |
| 09/16/2022 | 38.03% | Morgan Stanley | $252 → $257 | Maintains | Equal-Weight |
| 08/26/2022 | 55.75% | Barclays | $284 → $290 | Maintains | Overweight |
| 08/04/2022 | 61.13% | RBC Capital | $282 → $300 | Maintains | Outperform |
| 08/02/2022 | 61.13% | Keybanc | $283 → $300 | Maintains | Overweight |
| 07/29/2022 | 53.07% | Deutsche Bank | $270 → $285 | Maintains | Hold |
| 07/28/2022 | 61.13% | CFRA | → $300 | Upgrades | Hold → Buy |
| 07/20/2022 | 35.35% | Morgan Stanley | $268 → $252 | Maintains | Equal-Weight |
| 07/18/2022 | 55.75% | Citigroup | $300 → $290 | Maintains | Buy |
| 07/14/2022 | 45.01% | Deutsche Bank | $260 → $270 | Maintains | Hold |
| 07/13/2022 | 61.13% | Jefferies | $293 → $300 | Maintains | Buy |
| 07/01/2022 | 52% | Keybanc | $286 → $283 | Maintains | Overweight |
| 06/30/2022 | 57.37% | Jefferies | $308 → $293 | Maintains | Buy |
| 06/21/2022 | 53.07% | JP Morgan | $245 → $285 | Upgrades | Underweight → Overweight |
| 06/07/2022 | 43.94% | Morgan Stanley | $275 → $268 | Maintains | Equal-Weight |
| 06/06/2022 | 69.18% | B of A Securities | → $315 | Reinstates | → Buy |
| 06/06/2022 | 51.46% | RBC Capital | $280 → $282 | Maintains | Outperform |
| 04/29/2022 | 54.68% | Raymond James | $279 → $288 | Maintains | Outperform |
| 04/07/2022 | 47.7% | Morgan Stanley | $274 → $275 | Maintains | Equal-Weight |
| 03/15/2022 | 38.03% | Wolfe Research | $271 → $257 | Maintains | Peer Perform |
| 03/11/2022 | 50.38% | Wells Fargo | $250 → $280 | Maintains | Overweight |
| 03/08/2022 | 58.44% | Barclays | $311 → $295 | Maintains | Overweight |
| 03/01/2022 | 61.13% | Credit Suisse | $325 → $300 | Maintains | Outperform |
| 02/28/2022 | 39.64% | Deutsche Bank | $288 → $260 | Maintains | Hold |
| 02/28/2022 | 49.85% | Raymond James | $294 → $279 | Maintains | Outperform |
| 02/25/2022 | 74.55% | TD Cowen | $350 → $325 | Maintains | Outperform |
| 02/25/2022 | 53.61% | Keybanc | $311 → $286 | Maintains | Overweight |
| 01/26/2022 | 47.16% | Morgan Stanley | $294 → $274 | Maintains | Equal-Weight |
| 01/21/2022 | 54.68% | Deutsche Bank | $295 → $288 | Maintains | Hold |
| 01/05/2022 | 45.55% | JP Morgan | → $271 | Downgrades | Neutral → Underweight |
| 12/01/2021 | 57.9% | Morgan Stanley | $316 → $294 | Maintains | Equal-Weight |
| 11/19/2021 | 53.07% | Wells Fargo | $305 → $285 | Maintains | Overweight |
| 11/01/2021 | 57.9% | Raymond James | $296 → $294 | Maintains | Outperform |
| 10/29/2021 | 76.16% | Credit Suisse | $324 → $328 | Maintains | Outperform |
| 10/29/2021 | 67.03% | Keybanc | $302 → $311 | Maintains | Overweight |
| 09/10/2021 | 69.72% | Morgan Stanley | $270 → $316 | Maintains | Equal-Weight |
| 09/10/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 08/12/2021 | 61.13% | Argus Research | $288 → $300 | Maintains | Buy |
| 08/03/2021 | 58.98% | Raymond James | $261 → $296 | Maintains | Outperform |
| 07/30/2021 | 45.01% | Morgan Stanley | → $270 | Reiterates | → Equal-Weight |
| 07/30/2021 | 61.13% | Oppenheimer | $290 → $300 | Maintains | Outperform |
| 07/30/2021 | 67.57% | TD Cowen | $325 → $312 | Maintains | Outperform |
| 07/30/2021 | 69.18% | UBS | $290 → $315 | Maintains | Buy |
| 07/30/2021 | 73.48% | Credit Suisse | $314 → $323 | Maintains | Outperform |
| 07/19/2021 | 62.2% | Keybanc | $285 → $302 | Maintains | Overweight |
| 07/16/2021 | 63.81% | Wells Fargo | $280 → $305 | Maintains | Overweight |
| 07/15/2021 | 85.29% | Jefferies | $288 → $345 | Maintains | Buy |
| 07/13/2021 | — | LightShed Partners | Downgrades | Buy → Neutral | |
| 07/08/2021 | 58.44% | Deutsche Bank | $250 → $295 | Maintains | Hold |
| 06/08/2021 | 53.07% | Keybanc | $275 → $285 | Maintains | Overweight |
| 06/07/2021 | 55.75% | UBS | $275 → $290 | Maintains | Buy |
| 06/02/2021 | 45.01% | Morgan Stanley | $262 → $270 | Maintains | Equal-Weight |
| 05/14/2021 | 34.27% | Deutsche Bank | $240 → $250 | Maintains | Hold |
| 05/05/2021 | 50.38% | RBC Capital | $250 → $280 | Maintains | Outperform |
| 05/04/2021 | 40.18% | Raymond James | $244 → $261 | Maintains | Outperform |
| 04/30/2021 | 47.7% | UBS | $270 → $275 | Maintains | Buy |
| 04/30/2021 | 59.51% | Credit Suisse | $296 → $297 | Maintains | Outperform |
| 04/19/2021 | 40.72% | Morgan Stanley | $248 → $262 | Maintains | Equal-Weight |
| 04/12/2021 | 49.31% | Jefferies | → $278 | Initiates Coverage On | → Buy |
| 03/26/2021 | 47.7% | Keybanc | → $275 | Upgrades | Sector Weight → Overweight |
| 03/18/2021 | 42.33% | Wolfe Research | → $265 | Initiates Coverage On | → Outperform |
| 03/08/2021 | 34.27% | RBC Capital | $275 → $250 | Maintains | Outperform |
| 02/26/2021 | 58.98% | Credit Suisse | $307 → $296 | Maintains | Outperform |
| 02/26/2021 | 31.05% | Raymond James | $258 → $244 | Maintains | Outperform |
| 01/04/2021 | 38.03% | LightShed Partners | → $257 | Initiates Coverage On | → Buy |
| 12/11/2020 | 31.59% | Deutsche Bank | $295 → $245 | Downgrades | Buy → Hold |
| 11/05/2020 | 58.44% | Deutsche Bank | $300 → $295 | Maintains | Buy |
| 11/03/2020 | 61.66% | Credit Suisse | $300 → $301 | Maintains | Outperform |
| 11/03/2020 | 38.57% | Raymond James | $276 → $258 | Maintains | Outperform |
| 10/20/2020 | 31.05% | Morgan Stanley | $250 → $244 | Maintains | Equal-Weight |
| 10/06/2020 | 61.13% | Deutsche Bank | $305 → $300 | Maintains | Buy |
| 09/16/2020 | 53.07% | Wells Fargo | $290 → $285 | Maintains | Overweight |
| 07/31/2020 | 50.38% | SunTrust Robinson Humphrey | $275 → $280 | Maintains | Buy |
| 07/15/2020 | 58.98% | Barclays | → $296 | Initiates Coverage On | → Overweight |
| 07/13/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 07/10/2020 | 55.75% | Wells Fargo | $272 → $290 | Maintains | Overweight |
| 06/26/2020 | 56.29% | Deutsche Bank | $287 → $291 | Maintains | Buy |
| 06/15/2020 | 61.13% | Credit Suisse | → $300 | Reiterates | → Outperform |
| 06/12/2020 | 47.7% | SunTrust Robinson Humphrey | $270 → $275 | Maintains | Buy |
| 06/05/2020 | 54.14% | Deutsche Bank | → $287 | Reinstates | → Buy |
| 06/01/2020 | 34.27% | Morgan Stanley | $245 → $250 | Maintains | Equal-Weight |
| 05/22/2020 | 45.01% | Oppenheimer | → $270 | Upgrades | Perform → Outperform |
| 04/30/2020 | 61.13% | Credit Suisse | $308 → $300 | Maintains | Outperform |
| 04/28/2020 | 65.42% | Credit Suisse | → $308 | Initiates Coverage On | → Outperform |
| 04/27/2020 | 31.59% | Morgan Stanley | $218 → $245 | Maintains | Equal-Weight |
| 04/07/2020 | — | Wells Fargo | Upgrades | Equal-Weight → Overweight | |
| 04/02/2020 | 45.01% | UBS | → $270 | Upgrades | Neutral → Buy |
| 03/26/2020 | 13.33% | Raymond James | → $211 | Upgrades | Market Perform → Outperform |
| 03/25/2020 | — | Edward Jones | Upgrades | Hold → Buy | |
| 03/06/2020 | 50.38% | Citigroup | → $280 | Upgrades | Neutral → Buy |
| 02/26/2020 | 45.01% | UBS | $222 → $270 | Maintains | Neutral |
| 02/26/2020 | 46.62% | Keybanc | $254 → $273 | Maintains | Overweight |
| 02/19/2020 | 50.38% | Citigroup | $234 → $280 | Maintains | Neutral |
| 01/13/2020 | 45.01% | Goldman Sachs | $204 → $270 | Upgrades | Neutral → Buy |
| 01/10/2020 | 36.42% | Keybanc | $242 → $254 | Maintains | Overweight |
| 11/22/2019 | 17.08% | Morgan Stanley | $216 → $218 | Maintains | Equal-Weight |
| 11/01/2019 | 29.97% | Keybanc | $253 → $242 | Maintains | Overweight |
| 09/19/2019 | 16.01% | Morgan Stanley | $201 → $216 | Maintains | Equal-Weight |
| 09/04/2019 | 28.9% | Citigroup | $236 → $240 | Maintains | Neutral |
| 08/19/2019 | 35.88% | Keybanc | $225 → $253 | Maintains | Overweight |
| 08/01/2019 | 18.16% | JP Morgan | $200 → $220 | Maintains | Neutral |
| 07/15/2019 | 20.84% | Keybanc | $207 → $225 | Maintains | Overweight |
| 06/07/2019 | 19.23% | UBS | $195 → $222 | Downgrades | Buy → Neutral |
| 05/20/2019 | 7.95% | Morgan Stanley | $185 → $201 | Maintains | Equal-Weight |
| 05/09/2019 | 9.03% | RBC Capital | $195 → $203 | Maintains | Outperform |
| 04/15/2019 | — | Wells Fargo | Downgrades | Outperform → Market Perform | |
| 03/11/2019 | -0.64% | Morgan Stanley | $170 → $185 | Maintains | Equal-Weight |
| 03/06/2019 | 4.73% | RBC Capital | $173 → $195 | Maintains | Outperform |
| 03/04/2019 | -0.1% | Citigroup | $176 → $186 | Maintains | Neutral |
| 02/28/2019 | -0.64% | Keybanc | $180 → $185 | Maintains | Overweight |
| 02/28/2019 | — | Oppenheimer | Downgrades | Outperform → Market Perform | |
| 02/12/2019 | -3.32% | Keybanc | $170 → $180 | Maintains | Overweight |
| 12/12/2018 | -8.7% | Morgan Stanley | → $170 | Downgrades | Overweight → Equal-Weight |
| 11/16/2018 | -5.47% | Wells Fargo | $173 → $176 | Maintains | Outperform |
What is the target price for American Tower (AMT)?
The latest price target for American Tower (NYSE: AMT) was reported by JP Morgan on November 7, 2023. The analyst firm set a price target for $236.00 expecting AMT to rise to within 12 months (a possible 26.75% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for American Tower (AMT)?
The latest analyst rating for American Tower (NYSE: AMT) was provided by JP Morgan, and American Tower maintained their overweight rating.
When is the next analyst rating going to be posted or updated for American Tower (AMT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Tower, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Tower was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating American Tower (AMT) correct?
While ratings are subjective and will change, the latest American Tower (AMT) rating was a maintained with a price target of $218.00 to $236.00. The current price American Tower (AMT) is trading at is $186.19, which is out of the analyst's predicted range.